Containment laboratories fail certification for buildable reasons far more often than scientific ones. Sealing, room integrity, airflow direction and the details around penetrations are construction problems, and they are cheapest to solve before the walls go up.
Universities, medical research institutes, diagnostics companies, veterinary and agricultural laboratories, and increasingly the commercial biotech companies that graduate out of shared facilities and need their own space.
The work usually arrives in one of four ways. A new research program needs containment space that does not exist. An existing PC2 laboratory has to be uplifted to PC3 because the work has changed. A certification inspection has produced findings that have to be closed out. Or a lease has ended and the whole facility has to be rebuilt somewhere else.
The second of those, the PC2 to PC3 uplift, is the one people underestimate most consistently. We have written a short guide on it: PC2 to PC3: what the uplift actually involves.
PC2 is a well controlled laboratory. PC3 is a sealed box with directional airflow, and that difference is structural, not cosmetic.
The single most common and most expensive discovery on an uplift is that the existing room cannot be made tight enough without taking the linings off. That is a question worth answering before the budget is set, not after the contract is signed.
Containment facilities working with genetically modified organisms are certified by the Office of the Gene Technology Regulator against published guidelines for each containment level. Facilities working with other biological agents are generally assessed against AS/NZS 2243.3. Many facilities sit under both, and some also carry departmental requirements for imported biological material.
What that means practically is that your facility gets inspected against a written checklist by someone who has seen a lot of laboratories. Construction is not a supporting act in that inspection. Sealing, finishes, airflow and the physical barrier are most of the checklist.
We build backwards from that inspection. The room gets designed so it will pass, and the evidence gets assembled as the work proceeds rather than reconstructed afterwards.
| The problem | When it should have been caught |
|---|---|
| Penetrations sealed after the fact, in a way that cannot be decontaminated | Services coordination, during design |
| Ceiling system cannot achieve the required integrity because of how it is suspended | Design, when the ceiling system was selected |
| Airflow cannot be maintained because the room leaks | Design, and again at first fix |
| Airlock added late, and the new layout breaches exit travel distance | Design, before the certifier saw it |
| Finishes rejected because they will not survive the decontamination method | Specification, before ordering |
| No room to get the autoclave in once the walls are built | Design, at equipment schedule |
Every one of those is a design stage decision that becomes a construction stage disaster. That is the argument for getting a builder who understands containment into the conversation early, which is what our feasibility and pre-build review exists to do.
Talk it through with a licensed builder who has delivered GMP compliant rooms, before the design is locked. That is the point where the decisions are cheapest to change.